P2RY8 variants in lupus patients uncover a role for the receptor in immunological tolerance

Yuke He, Antonia E. Gallman, Chengmei Xie, Qian Shen, Jianyang Ma, Finn D. Wolfreys, Moriah Sandy, Todor Arsov, Xiaoqian Wu, Yuting Qin, Pingjing Zhang, Simon Jiang, Maurice Stanley, Philip Wu, Jingjing Tan, Huihua Ding, Haiyan Xue, Wei Chen, Jinping Xu, Lindsey A. CriswellJoanne Nititham, Marcin Adamski, A. Richard Kitching, Matthew C. Cook, Lanfang Cao, Nan Shen, Jason G. Cyster, Carola G. Vinuesa

Research output: Contribution to journalArticleResearchpeer-review

23 Citations (Scopus)

Abstract

B cell self-tolerance is maintained through multiple checkpoints, including restraints on intracellular signaling and cell trafficking. P2RY8 is a receptor with established roles in germinal center (GC) B cell migration inhibition and growth regulation. Somatic P2RY8 variants are common in GC-derived B cell lymphomas. Here, we identify germline novel or rare P2RY8 missense variants in lupus kindreds or the related antiphospholipid syndrome, including a "de novo" variant in a child with severe nephritis. All variants decreased protein expression, F-actin abundance, and GPCR-RhoA signaling, and those with stronger effects increased AKT and ERK activity and cell migration. Remarkably, P2RY8 was reduced in B cell subsets from some SLE patients lacking P2RY8 gene variants. Low P2RY8 correlated with lupus nephritis and increased age-associated B cells and plasma cells. By contrast, P2RY8 overexpression in cells and mice restrained plasma cell development and reinforced negative selection of DNA-reactive developing B cells. These findings uncover a role of P2RY8 in immunological tolerance and lupus pathogenesis.

Original languageEnglish
Article numbere20211004
Number of pages17
JournalJournal of Experimental Medicine
Volume219
Issue number1
DOIs
Publication statusPublished - 10 Dec 2021

Cite this